CRSP

CRISPR Therapeutics
CRSP

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$4.36B
EV
$2.72B
Shares Outstanding
91.75M
Beta
1.80

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$81.75
P/E 2025E
-
P/Revenue 2025E
92.76x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About CRISPR Therapeutics AG

gainify
CRSP

CRISPR Therapeutics AG

CRSP

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene ed...

Sector

Healthcare

Industry

Biotechnology

CEO

Kulkarni, Samarth

Employees

393

IPO Date

2016-10-19

Headquarters

Baarerstrasse 14, Zug, Zug, 6300, Switzerland

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.